$213.94
Price
$30.6B
Market Cap
—
P/E Ratio
-565.8
Forward P/E
$-1.63
EPS (TTM)
—
Dividend Yield
$1.1B
Cash
$214M
Total Debt
143M
Shares Out
$131.81
$256.36
52-Week Range
Institutional Ownership of NATERA INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for NATERA INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | +4.6% | 11.9K | $2M | $161.57 | |
| SELL | -9.2% | 2.9K | $470998 | $161.57 | |
| 2025-Q2 | |||||
| SELL | -0.2% | 11.4K | $2M | $154.53 | |
| BUY | NEW | 3.2K | $544494 | $154.53 | |
| 2025-Q1 | |||||
| SELL | -0.2% | 11.4K | $2M | $165.76 | |
| 2024-Q4 | |||||
| SELL | -28.9% | 11.4K | $2M | $146.06 | |
| 2024-Q3 | |||||
| BUY | +0.6% | 16.1K | $2M | $114.57 | |
| 2024-Q2 | |||||
| SELL | -7.8% | 16.0K | $2M | $105.52 | |
| 2024-Q1 | |||||
| SELL | -20.3% | 17.3K | $2M | $69.92 | |
| 2023-Q4 | |||||
| BUY | +4.8% | 21.8K | $1M | $52.12 | |
| 2023-Q3 | |||||
| BUY | +3.7% | 20.8K | $919294 | $51.02 | |
| 2023-Q2 | |||||
| BUY | +0.8% | 20.0K | $974465 | $51.00 | |
| 2023-Q1 | |||||
| BUY | +1.1% | 19.9K | $1M | $46.55 | |
| 2022-Q4 | |||||
| BUY | +17.3% | 19.6K | $789059 | $41.25 | |
| 2022-Q3 | |||||
| BUY | NEW | 16.7K | $734000 | $48.51 | |
Insider Trading for NATERA INC
6 Months Insider Sentiment
Buy $0
Sell $6.3M
0
Buys
19
Sells
-6.3M
Net
9
Grants
Largest
$1.1M
Moshkevich
$972K
Chapman
$506K
Chapman
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 14, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | GRANT | 44.7K | — | — |
| Jan 14, 2026 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | GRANT | 37.2K | — | — |
| Jan 14, 2026 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | GRANT | 44.7K | — | — |
| Jan 14, 2026 | Jonathan Sheena | Director | GRANT | 7.5K | — | — |
| Jan 14, 2026 | Steven Leonard Chapman | CEO AND PRESIDENT | GRANT | 152.7K | — | — |
| Jan 14, 2026 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | GRANT | 59.6K | — | — |
| Jan 05, 2026 | Jonathan Sheena | Director | EXERCISE | 39.6K | $9.59 | $380K |
| Jan 02, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1.7K | $229.43 | $381K |
| Jan 02, 2026 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 2.2K | $228.64 | $506K |
| Jan 02, 2026 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 1.6K | $229.67 | $375K |
| Jan 02, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1.3K | $228.33 | $295K |
| Dec 19, 2025 | Jonathan Sheena | Director | SELL | 550 | $226.36 | $124K |
| Dec 19, 2025 | Jonathan Sheena | Director | SELL | 200 | $224.89 | $45K |
| Dec 17, 2025 | Jonathan Sheena | Director | SELL | 1.3K | $227.44 | $307K |
| Dec 17, 2025 | Jonathan Sheena | Director | SELL | 130 | $228.28 | $30K |
| Dec 17, 2025 | Jonathan Sheena | Director | SELL | 1.6K | $226.54 | $361K |
| Dec 15, 2025 | Jonathan Sheena | Director | GRANT | 1.1K | — | — |
| Dec 15, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | GRANT | 115 | — | — |
| Dec 12, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | EXERCISE | 8.9K | $9.59 | $85K |
| Dec 12, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | EXERCISE | 13.5K | $9.59 | $129K |
| Dec 12, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 4.7K | $230.76 | $1.1M |
| Dec 12, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | GRANT | 180 | — | — |
| Dec 09, 2025 | Jonathan Sheena | Director | EXERCISE | 4.4K | $9.29 | $41K |
| Dec 05, 2025 | Rowan E Chapman | Director | SELL | 4.0K | $243.08 | $972K |
| Dec 05, 2025 | Rowan E Chapman | Director | SELL | 366 | $243.39 | $89K |
| Dec 05, 2025 | Rowan E Chapman | Director | EXERCISE | 4.0K | $32.15 | $129K |
| Dec 04, 2025 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | EXERCISE | 6.9K | $19.68 | $136K |
| Dec 01, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1.5K | $238.24 | $364K |
| Dec 01, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 956 | $239.44 | $229K |
| Dec 01, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 1.4K | $237.05 | $330K |
| Dec 01, 2025 | Steven Leonard Chapman | CEO AND PRESIDENT | SELL | 2.0K | $238.13 | $488K |
| Dec 01, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 749 | $237.23 | $178K |
| Dec 01, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 474 | $239.53 | $114K |
| Dec 01, 2025 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 250 | $237.77 | $59K |